The AI model Claude has designed 35,000 antibodies in just one month, opening a new path for developing treatments that block IgE, the key driver of food allergies.
| Imagine your daily life where you have to meticulously check ingredient labels out of fear before eating anything containing peanuts or milk. A normal meal can be a life-threatening challenge for some. Food allergies restrict many areas of daily life in this way [Source: Adults with Food Allergies- Managing Your Allergies | FARE](https://www.foodallergy.org/living-food-allergy/information-you/adults-food-allergies). Until now, the extent of treatment has been managing allergic reactions once they occur or cautiously avoiding the causative substances Source: Allergy Basics: What Happens During an Allergic Reaction?. Recently, however, artificial intelligence (AI) has begun a new challenge to break down this complex barrier of immunity. |
Why is this important?
Food allergies go beyond the inconvenience of not being able to eat certain foods, deeply affecting overall quality of life. Many patients suffer from multiple types of allergies simultaneously, and existing treatments often have limited effectiveness Source: Treatment of food allergy: oral immunotherapy, biologics and beyond…. If AI can design treatments that fundamentally suppress these allergic reactions, the fear and restrictions experienced by patients will be dramatically reduced. This research is a significant step toward a future where, beyond mere technological progress, countless people can sit at the dining table with peace of mind.
Easy to understand: IgE and the ‘Immune Alarm System’
| Our body’s immune system is a sturdy defense force that protects us from external intruders. However, in the bodies of people with allergies, this system works in the wrong direction. A key protein that plays a central role here is ‘IgE (Immunoglobulin E)’ [Source: Frontiers | Scientific developments in understanding food allergy…](https://www.frontiers.org/journals/immunology/articles/10.3389/fimmu.2025.1572283/full). |
To put it simply, IgE is like an ‘alarm system’ that triggers allergic reactions. When a specific food (antigen) enters the body, this alarm system malfunctions, calling in a ‘fire truck’ known as an allergic reaction. The problem is that the fire truck is dispatched and throws our bodies into chaos even when there is no actual fire.
In this study, researchers are utilizing Claude (an AI model developed by Anthropic) to design ‘disruptor antibodies’ that neutralize this IgE Source: Claude в разработке лекарств: первые результаты. These antibodies designed by Claude play a role in binding tightly to or neutralizing IgE, the alarm system, to prevent the fire truck (allergic reaction) from being dispatched. In particular, because this anti-IgE antibody can lower overall IgE levels regardless of the specific type of allergy, it offers great hope for patients suffering from multiple food allergies Source: Treatment of food allergy: oral immunotherapy, biologics and beyond….
Current Situation: The ‘Antibody Design Recipe’ Written by AI
In the past, developing such antibodies required scientists to go through years of tens of thousands of trial-and-error sessions in the laboratory. But with the emergence of AI, the speed has completely changed. In just one short month, Claude generated a staggering 35,000 antibody designs Source: Claude designs 35,000 antibodies in a month for allergy research.
Among these vast designs, promising candidate substances for food allergy treatments have been discovered after initial testing Source: Claude designs 35,000 antibodies in a month for allergy research. Claude has evolved beyond simple conversation into a tool for processing massive amounts of data and solving complex scientific challenges, and this capability is changing the landscape of drug development Source: Claude.
What will happen in the future?
| Researchers are continuing their study with the goal of developing a ‘best-in-class IgE disruptor’ Source: Claude в разработке лекарств: первые результаты. Of course, this does not mean it will become a medicine that can be prescribed at hospitals tomorrow. However, the fact that substances with verified real-world effects are emerging from the tens of thousands of candidates designed by AI suggests that the ‘bottleneck of time and cost,’ which is the greatest difficulty in new drug development, is being significantly resolved. Moving forward, we should watch closely to see what surprising changes these AI-based biotechnologies will bring to the prevention, diagnosis, and treatment of allergies as a whole [Source: Frontiers | Scientific developments in understanding food allergy…](https://www.frontiers.org/journals/immunology/articles/10.3389/fimmu.2025.1572283/full). |
References
- Treatment of food allergy: oral immunotherapy, biologics and beyond… (https://pmc.ncbi.nlm.nih.gov/articles/PMC10330596/)
- Claude designs 35,000 antibodies in a month for allergy research (https://interestingengineering.com/ai-robotics/claude-35000-antibody-designs-drug-discovery)
-
Frontiers Scientific developments in understanding food allergy… (https://www.frontiers.org/journals/immunology/articles/10.3389/fimmu.2025.1572283/full) - Claude (https://claude.com/)
- Claude в разработке лекарств: первые результаты (https://aptekium.com/2026/10/claude-drug-development-early-results.html)
- Allergy Basics: What Happens During an Allergic Reaction? (https://www.webmd.com/allergies/allergy-basics)
-
Adults with Food Allergies- Managing Your Allergies FARE (https://www.foodallergy.org/living-food-allergy/information-you/adults-food-allergies)
- IgG
- IgE
- IgM
- 3,500
- 15,000
- 35,000
- They react only to specific allergy-causing substances
- They lower IgE levels regardless of antigen specificity
- They can only treat skin allergies